Bu sayfanın çevirisi deneyseldir ve geliştirilme aşamasındadır. imlerinizi bekliyoruz!
Maternus-Kliniken Geçmiş Kazanç Performansı
Geçmiş kriter kontrolleri 0/6
Maternus-Kliniken's earnings have been declining at an average annual rate of -12.3%, while the Healthcare industry saw earnings growing at 3.6% annually. Revenues have been declining at an average rate of 3.9% per year.
Anahtar bilgiler
-12.3%
Kazanç büyüme oranı
-12.5%
EPS büyüme oranı
| Healthcare Sektör Büyümesi | 15.7% |
| Gelir büyüme oranı | -3.9% |
| Özkaynak getirisi | n/a |
| Net Marj | -6.4% |
| Son Kazanç Güncellemesi | 30 Jun 2024 |
Yakın geçmiş performans güncellemeleri
Recent updates
Maternus-Kliniken Aktiengesellschaft's (ETR:MAK) 25% Share Price Plunge Could Signal Some Risk
Aug 21
Maternus-Kliniken Aktiengesellschaft (ETR:MAK) Stocks Shoot Up 27% But Its P/S Still Looks Reasonable
Jul 05A Piece Of The Puzzle Missing From Maternus-Kliniken Aktiengesellschaft's (ETR:MAK) Share Price
Mar 13Maternus-Kliniken (ETR:MAK) Will Be Hoping To Turn Its Returns On Capital Around
Jul 27The Returns On Capital At Maternus-Kliniken (ETR:MAK) Don't Inspire Confidence
Feb 22Some Investors May Be Worried About Maternus-Kliniken's (ETR:MAK) Returns On Capital
Jul 27Estimating The Fair Value Of Maternus-Kliniken Aktiengesellschaft (ETR:MAK)
Jun 10Gelir ve Gider Dağılımı
Maternus-Kliniken nasıl para kazanır ve harcar. LTM bazında en son bildirilen kazançlara dayanmaktadır.
Kazanç ve Gelir Geçmişi
| Tarih | Gelir | Kazançlar | G+A Giderleri | Ar-Ge Giderleri |
|---|---|---|---|---|
| 30 Jun 24 | 107 | -7 | 0 | 0 |
| 31 Mar 24 | 107 | -11 | 0 | 0 |
| 31 Dec 23 | 102 | -14 | 0 | 0 |
| 30 Sep 23 | 102 | -17 | 0 | 0 |
| 30 Jun 23 | 102 | -19 | 0 | 0 |
| 31 Mar 23 | 105 | -16 | 0 | 0 |
| 31 Dec 22 | 107 | -14 | 0 | 0 |
| 30 Sep 22 | 108 | -10 | 0 | 0 |
| 30 Jun 22 | 110 | -6 | 0 | 0 |
| 31 Mar 22 | 111 | -4 | 0 | 0 |
| 31 Dec 21 | 111 | -3 | 0 | 0 |
| 30 Sep 21 | 114 | -5 | 0 | 0 |
| 30 Jun 21 | 116 | -7 | 0 | 0 |
| 31 Mar 21 | 115 | -8 | 0 | 0 |
| 31 Dec 20 | 114 | -10 | 0 | 0 |
| 30 Sep 20 | 116 | -10 | 1 | 0 |
| 30 Jun 20 | 117 | -10 | 2 | 0 |
| 31 Mar 20 | 121 | -10 | 3 | 0 |
| 31 Dec 19 | 124 | -10 | 5 | 0 |
| 30 Sep 19 | 125 | -7 | 6 | 0 |
| 30 Jun 19 | 125 | -5 | 8 | 0 |
| 31 Mar 19 | 125 | -3 | 11 | 0 |
| 31 Dec 18 | 124 | -2 | 13 | 0 |
| 30 Sep 18 | 125 | -2 | 17 | 0 |
| 30 Jun 18 | 126 | -2 | 21 | 0 |
| 31 Mar 18 | 126 | -2 | 17 | 0 |
| 31 Dec 17 | 127 | -1 | 14 | 0 |
| 30 Sep 17 | 127 | 0 | 14 | 0 |
| 30 Jun 17 | 126 | 2 | 14 | 0 |
| 31 Mar 17 | 125 | 1 | 14 | 0 |
| 31 Dec 16 | 124 | 1 | 14 | 0 |
| 30 Sep 16 | 124 | 4 | 21 | 0 |
| 30 Jun 16 | 124 | 2 | 14 | 0 |
| 31 Mar 16 | 124 | 2 | 14 | 0 |
| 31 Dec 15 | 123 | 2 | 14 | 0 |
| 30 Sep 15 | 123 | 28 | 14 | 0 |
| 30 Jun 15 | 124 | 28 | 14 | 0 |
| 31 Mar 15 | 123 | 28 | 14 | 0 |
| 31 Dec 14 | 122 | 27 | 14 | 0 |
| 30 Sep 14 | 120 | -9 | 15 | 0 |
| 30 Jun 14 | 118 | -10 | 15 | 0 |
| 31 Mar 14 | 115 | -11 | 15 | 0 |
| 31 Dec 13 | 114 | -13 | 15 | 0 |
Kaliteli Kazançlar: MAK is currently unprofitable.
Büyüyen Kar Marjı: MAK is currently unprofitable.
Serbest Nakit Akışı ve Kazanç Analizi
Geçmiş Kazanç Büyüme Analizi
Kazanç Eğilimi: MAK is unprofitable, and losses have increased over the past 5 years at a rate of 12.3% per year.
Büyüme Hızlandırma: Unable to compare MAK's earnings growth over the past year to its 5-year average as it is currently unprofitable
Kazançlar vs. Sektör: MAK is unprofitable, making it difficult to compare its past year earnings growth to the Healthcare industry (30.9%).
Özkaynak Getirisi
Yüksek ROE: MAK's liabilities exceed its assets, so it is difficult to calculate its Return on Equity.